IESG:LSE:LSE-iShares MSCI Europe SRI UCITS ETF EUR (Acc) (GBX)

ETF | Others |

Last Closing

USD 5864

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.77K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+2.50 (+1.34%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.38 (+2.05%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.48 (+2.67%)

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.29 (+2.11%)

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.25 (-1.73%)

USD 266.08B
0QZO:LSE 0QZO

+1.15 (+1.23%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+3.58 (+2.13%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

+0.79 (+2.58%)

USD 200.01B
0R24:LSE Intel Corp.

+0.28 (+1.33%)

USD 196.14B

ETFs Containing IESG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.73% 58% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.73% 55% F 57% F
Trailing 12 Months  
Capital Gain 13.27% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.27% 64% D 64% D
Trailing 5 Years  
Capital Gain 46.04% 69% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.04% 67% D+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.52% 66% D+ 68% D+
Dividend Return 9.52% 65% D 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.57% 58% F 74% C
Risk Adjusted Return 82.27% 86% B+ 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike